Cassava Sciences (NASDAQ:SAVA) stock is in a tailspin after a lab denied it had prepared recent results for the biotech’s experimental Alzheimer’s disease treatment. Source: pathdoc / Shutterstock.com Following the news, Cassava shares fell approximately 50%, eliminating roughly $2.4 billion of value over three trading days. The rejection contradicts a statement from Cassava that Quanterix
0 Comments
Are Private Companies’ Financials Public? In short, not in the United States. While many may speculate about the business revenue or look for financial statements of private companies, typically they will find this to be difficult. As the name implies, a private company is not required to disclose financial information to the public. Privately-owned companies include
0 Comments
It’s been a little more than three weeks since Zomedica (NYSEAMERICAN:ZOM) reported its Q2 results. Despite reasonably healthy sales, ZOM stock gained just 14% from Aug. 11 through the end of the month.  Source: Postmodern Studio / Shutterstock.com Another InvestorPlace columnist, Ian Bezek, recently argued that Zomedica needs to raise its revenues considerably before investors
0 Comments
Buckle up. It’s time to binge again. September is absolutely packed with streaming offerings, with new seasons of beloved fan favorites and an impressive slate of eagerly anticipated newcomers. And, for those on a budget, here’s the highlight: The best of the bunch can be had for a very reasonable $25 in total, across three
0 Comments
Novavax (NASDAQ:NVAX) stock could trade in the $100 billion market capitalization range like BioNTech (NASDAQ:BNTX) or Moderna (NASDAQ:MRNA). Except, unlike those companies, Novavax has not yet delivered. Source: Ascannio/Shutterstock.com It might be among the most-watched firms that did not yet bring a Covid-19 vaccine to market. Chances are low that it will slump like Altimmune
0 Comments
On Sept. 21, 2021, Investopedia, in partnership with another member of the Dotdash online publishing family, Verywell, is set to host a unique virtual conference: “Your Money, Your Health.” This conference will help financial advisors coach clients on the great financial reset, equip investors with smart insights now, and provide you with the most reliable
0 Comments
I have been wrong on Alibaba (NYSE:BABA) thus far. I kept expecting the “Dogs of the Dow” theory to come into play, where underperforming, high-quality tech stocks would fetch a bid. For BABA stock — and others, like Amazon (NASDAQ:AMZN) until very recently — that hasn’t panned out too well. Source: BigTunaOnline / Shutterstock.com  
0 Comments
Investors were already selling Skillz (NYSE:SKLZ) stock before the company posted quarterly earnings results on Aug. 3. Source: Rawpixel.com/Shutterstock.com After the report, SKLZ stock slumped further. Clearly there is something the market does not like about this electronic gaming and multimedia firm. At these levels, investors might think the stock has less risk and more
0 Comments
Support.com (NASDAQ:SPRT) holds its special meeting on Sept. 10 to vote on its merger with Greenridge Generation Holdings. The merger’s acceptance requires that more than 50% of owners of SPRT stock vote to approve the deal. Source: Shutterstock.com The two parties announced their merger on March 22. The day before the merger announcement, SPRT closed
0 Comments
Oil prices pushed past $70 for the first time in a month in late-day trading Thursday. The rally is breathing new life into the energy sector, which is up 2.5% at this writing. For the past quarter, energy stocks have been lagging the broader market, so shareholders are cheering the newfound strength. To celebrate the
0 Comments